YU30592A - Novi derivati indola i postupci dobijanja - Google Patents
Novi derivati indola i postupci dobijanjaInfo
- Publication number
- YU30592A YU30592A YU30592A YU30592A YU30592A YU 30592 A YU30592 A YU 30592A YU 30592 A YU30592 A YU 30592A YU 30592 A YU30592 A YU 30592A YU 30592 A YU30592 A YU 30592A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- alkyl
- alkylamino
- benzyl
- indole derivatives
- optionally substituted
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title abstract 2
- 229940054051 antipsychotic indole derivative Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- -1 polymethylene chains Polymers 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
NOVI DERIVATI INDOLA I POSTUPCI DOBIJANJA, pronalazak se odnosi na derivate formule u kojoj, R1 i R2 predstavljaju H, alkil, alkenil, cikloalkil, N-alkilamino- ili N,N-dialkilaminoalkil, benzil, piridilmetil ili fenil eventualno supstituisane, R3 i R4 predstavljaju H, halogen, alkil, alkoksi, alkiltio, CF3, NO2, N-alkilamino ili N,N-dialkilamino, benzil ili fenil eventualno supstituisane, R5 predstavlja H, alkil, cikloalkil ili benzil eventualno supstituisane, R6 označava radikal alkila, fenila ili heterocilila eventualno supstituisane, Z označava biradikale:-(CH2)n-C(R7R8)-(CH2)p-, -CH=CH-C(R7R8)-u kojima n=0-2, p=0-2 i n+p-2, R7 i R8 predstavljaju H, alkil, alkenil, cikloalkil, N-alkilamino, N,N-dialkilamino, N-alkilamino- ili N,N-dialkilaminoalkil, benzil ili fenil koji mogu da budu supstituisani, ili formiraju zajedno lance polimetilena ili oksi-, tia- ili aminopolimetilena, kao na njihove tautomerne oblike, postupke za njihovo dobijanje i primenu kao lekova hipolipidemianta, anti-arteroskleroznih i antidijabetičnih.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI9210305A SI9210305A (en) | 1991-03-26 | 1992-03-26 | Indole derivatives, processes for their preparation and medicaments containing them |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9103618A FR2674522B1 (fr) | 1991-03-26 | 1991-03-26 | Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
YU30592A true YU30592A (sh) | 1994-12-28 |
Family
ID=9411107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU30592A YU30592A (sh) | 1991-03-26 | 1992-03-26 | Novi derivati indola i postupci dobijanja |
Country Status (25)
Country | Link |
---|---|
US (1) | US5219859A (sh) |
EP (1) | EP0506532B1 (sh) |
JP (1) | JPH0597802A (sh) |
KR (1) | KR950007753B1 (sh) |
AT (1) | ATE111078T1 (sh) |
AU (1) | AU658609B2 (sh) |
CA (1) | CA2063170A1 (sh) |
CS (1) | CS89592A3 (sh) |
DE (1) | DE69200378T2 (sh) |
DK (1) | DK0506532T3 (sh) |
ES (1) | ES2064149T3 (sh) |
FR (1) | FR2674522B1 (sh) |
HU (1) | HUT65489A (sh) |
IE (1) | IE65366B1 (sh) |
IL (1) | IL101248A (sh) |
MA (1) | MA22474A1 (sh) |
MX (1) | MX9201365A (sh) |
NO (1) | NO178260C (sh) |
NZ (1) | NZ242078A (sh) |
OA (1) | OA09573A (sh) |
RU (1) | RU2074179C1 (sh) |
SI (1) | SI9210305A (sh) |
TN (1) | TNSN92022A1 (sh) |
YU (1) | YU30592A (sh) |
ZA (1) | ZA922163B (sh) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2687402B1 (fr) * | 1992-02-14 | 1995-06-30 | Lipha | Nouveaux azaindoles, procedes de preparation et medicaments les contenant. |
US6001860A (en) * | 1992-05-28 | 1999-12-14 | Pfizer Inc. | N-aryl and N-heteroarylurea derivatives as inhibitors of acyl coenzyme A: Cholesterol acyl transferase (ACAT) |
NZ250916A (en) * | 1993-02-27 | 1995-08-28 | Nihon Nohyaku Co Ltd | N-heteroaryl-n'-phenylureas, their use as acat inhibitors |
IL109568A0 (en) * | 1993-05-19 | 1994-08-26 | Fujisawa Pharmaceutical Co | Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
DE4401893A1 (de) * | 1994-01-24 | 1995-07-27 | Bayer Ag | Substituierte Arylharnstoffe |
JP3720395B2 (ja) * | 1994-09-20 | 2005-11-24 | 京都薬品工業株式会社 | 新規ヘテロ環誘導体、その製造方法およびその医薬用途 |
JP3314938B2 (ja) * | 1995-06-06 | 2002-08-19 | ファイザー・インコーポレーテッド | グリコーゲンホスホリラーゼ抑制剤としての置換されたn−(インドール−2−カルボニル)−グリシンアミド類および誘導体 |
MX9709874A (es) | 1995-06-06 | 1998-03-31 | Pfizer | N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN. |
KR100241643B1 (ko) * | 1995-06-06 | 2000-03-02 | 디. 제이. 우드 | 당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체 |
AU679887B2 (en) * | 1995-09-11 | 1997-07-10 | Nihon Nohyaku Co., Ltd. | Azole derivatives, their use, production and usage |
DK0866059T3 (da) * | 1995-10-05 | 2002-03-25 | Kyoto Pharma Ind | Nye heterocykliske derivater og medicinsk anvendelse deraf |
EP0773218A1 (en) * | 1995-11-13 | 1997-05-14 | Mitsubishi Chemical Corporation | N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis |
FR2763334A1 (fr) * | 1997-05-13 | 1998-11-20 | Lipha | Derives anthraniliques |
US6521650B1 (en) * | 1997-12-16 | 2003-02-18 | Pfizer, Inc. | Amines as pharmaceutical agents |
TR200001795T2 (tr) * | 1997-12-16 | 2000-11-21 | Warner-Lambert Company | 1-İkameli-1-Aminometil-sikloalkan türevleri (=Gabapentin analogları), bunların hazırlanması ve nörolojik bozuklukların tedavisinde kullanımı. |
IL135315A0 (en) * | 1997-12-16 | 2001-05-20 | Warner Lambert Co | 4(3)-substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
SK282727B6 (sk) | 1997-12-19 | 2002-11-06 | Slovakofarma, A. S. | 1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy |
US6277877B1 (en) | 2000-08-15 | 2001-08-21 | Pfizer, Inc. | Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors |
US7153882B2 (en) | 2000-11-02 | 2006-12-26 | The United States Of America As Represented By The Department Of Health And Human Services | Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
MXPA04010780A (es) * | 2002-05-03 | 2005-03-07 | Warner Lambert Co | Antagonistas de bombesina. |
RU2318808C2 (ru) * | 2002-07-17 | 2008-03-10 | Киото Фармасьютикал Индастриз, Лтд. | Новое соединение индолина и его применение в медицине |
EP1615900A1 (en) * | 2003-04-01 | 2006-01-18 | Eli Lilly And Company | Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors |
RU2008120141A (ru) | 2005-11-30 | 2010-01-10 | Ф. Хоффманн-Ля Рош Аг (Ch) | 3-амино-2-арилпропилазаиндолы и их применения |
CA2629962A1 (en) | 2005-11-30 | 2007-06-07 | F. Hoffmann-La Roche Ag | 3-amino-1-arylpropyl indoles and aza-substituted indoles |
RU2361581C2 (ru) * | 2007-09-14 | 2009-07-20 | Закрытое Акционерное Общество "Мастерклон" | Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний |
SK287385B6 (sk) | 2007-11-27 | 2010-08-09 | Hameln-Rds, A. S. | 1,3-Disubstituované močoviny, spôsob ich prípravy a použitia |
CN104628621A (zh) * | 2015-01-22 | 2015-05-20 | 湖南华腾制药有限公司 | 一种氟取代吲哚衍生物的制备方法 |
JP7397672B2 (ja) | 2017-06-26 | 2023-12-13 | ルネラ・バイオテック・インコーポレーテッド | ミトケトシン:癌細胞におけるケトン代謝を標的とするミトコンドリアに基づく治療薬 |
CN113784962A (zh) | 2019-02-27 | 2021-12-10 | 加利福尼亚大学董事会 | 用于治疗脑部疾病的氮杂环庚三烯并-吲哚类和其他杂环 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55151505A (en) * | 1979-05-14 | 1980-11-26 | Kuraray Co Ltd | Indole agricultural and horticultural fungicide |
CA1299174C (en) * | 1987-02-02 | 1992-04-21 | Michael Edward Flaugh | Alkylmelatonins |
EP0375133A1 (en) * | 1988-11-14 | 1990-06-27 | The Upjohn Company | Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents |
PH30133A (en) * | 1989-09-07 | 1997-01-21 | Abbott Lab | Indole-, benzofuran-, and benzothiophene-containing lipoxygenase inhibiting compounds |
MX22406A (es) * | 1989-09-15 | 1994-01-31 | Pfizer | Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat). |
ATE130002T1 (de) * | 1990-08-13 | 1995-11-15 | Hoechst Roussel Pharma | 1-(pyridinylalkyl)-1h-indole, -indoline und analoge. |
FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
WO1993005020A1 (en) * | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
-
1991
- 1991-03-26 FR FR9103618A patent/FR2674522B1/fr not_active Expired - Fee Related
-
1992
- 1992-03-16 IL IL10124892A patent/IL101248A/en not_active IP Right Cessation
- 1992-03-17 CA CA002063170A patent/CA2063170A1/en not_active Abandoned
- 1992-03-20 DK DK92400764.4T patent/DK0506532T3/da active
- 1992-03-20 US US07/855,544 patent/US5219859A/en not_active Expired - Fee Related
- 1992-03-20 AT AT92400764T patent/ATE111078T1/de active
- 1992-03-20 ES ES92400764T patent/ES2064149T3/es not_active Expired - Lifetime
- 1992-03-20 DE DE69200378T patent/DE69200378T2/de not_active Expired - Fee Related
- 1992-03-20 NZ NZ242078A patent/NZ242078A/en unknown
- 1992-03-20 EP EP92400764A patent/EP0506532B1/fr not_active Expired - Lifetime
- 1992-03-20 AU AU13094/92A patent/AU658609B2/en not_active Ceased
- 1992-03-23 MA MA22763A patent/MA22474A1/fr unknown
- 1992-03-24 IE IE920937A patent/IE65366B1/en not_active IP Right Cessation
- 1992-03-24 NO NO921141A patent/NO178260C/no unknown
- 1992-03-25 HU HU9200997A patent/HUT65489A/hu unknown
- 1992-03-25 CS CS92895A patent/CS89592A3/cs unknown
- 1992-03-25 RU SU925011235A patent/RU2074179C1/ru active
- 1992-03-25 JP JP4067252A patent/JPH0597802A/ja active Pending
- 1992-03-25 ZA ZA922163A patent/ZA922163B/xx unknown
- 1992-03-26 YU YU30592A patent/YU30592A/sh unknown
- 1992-03-26 TN TNTNSN92022A patent/TNSN92022A1/fr unknown
- 1992-03-26 MX MX9201365A patent/MX9201365A/es not_active IP Right Cessation
- 1992-03-26 KR KR1019920005020A patent/KR950007753B1/ko not_active IP Right Cessation
- 1992-03-26 SI SI9210305A patent/SI9210305A/sl unknown
- 1992-03-26 OA OA60177A patent/OA09573A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
HU9200997D0 (en) | 1992-05-28 |
DE69200378D1 (de) | 1994-10-13 |
NO178260C (no) | 1996-02-21 |
NZ242078A (en) | 1994-10-26 |
SI9210305A (en) | 1996-02-29 |
RU2074179C1 (ru) | 1997-02-27 |
OA09573A (fr) | 1993-01-31 |
NO921141D0 (no) | 1992-03-24 |
HUT65489A (en) | 1994-06-28 |
CA2063170A1 (en) | 1992-09-27 |
US5219859A (en) | 1993-06-15 |
EP0506532B1 (fr) | 1994-09-07 |
AU658609B2 (en) | 1995-04-27 |
IE65366B1 (en) | 1995-10-18 |
MX9201365A (es) | 1992-10-01 |
FR2674522A1 (fr) | 1992-10-02 |
MA22474A1 (fr) | 1992-10-01 |
FR2674522B1 (fr) | 1993-07-16 |
DK0506532T3 (da) | 1995-02-20 |
NO921141L (no) | 1992-09-28 |
ZA922163B (en) | 1993-09-27 |
IL101248A0 (en) | 1992-11-15 |
NO178260B (no) | 1995-11-13 |
KR950007753B1 (ko) | 1995-07-14 |
IL101248A (en) | 1996-12-05 |
AU1309492A (en) | 1992-10-01 |
IE920937A1 (en) | 1992-10-07 |
ES2064149T3 (es) | 1995-01-16 |
EP0506532A1 (fr) | 1992-09-30 |
JPH0597802A (ja) | 1993-04-20 |
TNSN92022A1 (fr) | 1993-06-08 |
ATE111078T1 (de) | 1994-09-15 |
CS89592A3 (en) | 1992-10-14 |
KR920018022A (ko) | 1992-10-21 |
DE69200378T2 (de) | 1995-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU30592A (sh) | Novi derivati indola i postupci dobijanja | |
CO5031253A1 (es) | Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen | |
YU128091A (sh) | Derivati hinuklidina | |
ATE149999T1 (de) | Monofluorierte derivate von n-propargyl-1- aminoindan und deren verwendung als monoamino- oxidaseinhibitoren | |
HN1998000035A (es) | Nuevos derivados del acido hexanoico | |
CY1110399T1 (el) | Ρυθμιστες της τετραϋδροπυρανυλο κυκλοπεντυλο τετραϋδροπυριδοπυριδινης για την ενεργοτητα των υποδοχεων των χημειοκινων | |
YU29892A (sh) | Postupak za stereoselektivno dobijanje supstituisanih piperidina | |
YU30491A (sh) | Derivati 1-piridilimidazola i njegova proizvodnja i upotreba | |
AR003955A1 (es) | Derivados de n-(indol-2-carbonil)-glicinamidas, procedimiento para su obtencion y composiciones que los contienen. | |
ES2180530T3 (es) | Sulfonamidas de tiofeno utiles como inhibidores de anhidrasa carbonica. | |
ES2053451T3 (es) | Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles. | |
AR007828A1 (es) | Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos | |
NO960630L (no) | Heterocykler anvendelige som neurokinin antagonister | |
ES531121A0 (es) | Procedimiento de preparar derivados benzofuran- o benzopirancar-boxamidicos | |
AR017542A1 (es) | Compuestos [indol]naftopiranos, procedimiento para prepararlos, un (co)polimero, un compuesto fotocromatico, una composicion fotocromatica, una matriz(co)polimerica, un articulo solar y un vidriado, todos basados en los compuestos | |
DK0489877T3 (da) | Antiatherosklerotiske og antithrombotiske 2-amino-6-phenyl-4H-pyran-4-oner | |
DE69727305D1 (de) | Verwendung neurogen-entzuendungshemmender verbindungen und zusammensetzungen | |
CY1106396T1 (el) | Γραμμικες ή κυκλικες ουριες, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τις πepιεχουν | |
AR027134A1 (es) | Derivados de indol. | |
ES2117678T3 (es) | Derivados de eteres milbemicina, su preparacion y su aplicacion terapeutica y agroquimica. | |
DK1017681T3 (da) | Hydrazon-benzazulenderivater, farmaceutiske præparater og mellemprodukter | |
AR006084A1 (es) | Aminofeniluracilos substituidos y empleo de los mismos para la lucha contra las plantas indeseables | |
ES2123122T3 (es) | Derivados de tetrahidrocarbazol como agonistas similares a 5-ht1. | |
ATE199252T1 (de) | 1-amino-3-benzyluracile | |
ES542074A0 (es) | Procedimiento para preparar derivados de benzotiazol |